Exposure to low mercury concentration in vivo impairs myocardial contractile function

Toxicology and Applied Pharmacology

Volumn 255, Issue 2, 2011, Pages 193-199

  Furieri, Lorena Barros ^a   Fioresi, Mirian ^a   Junior, Rogério Faustino Ribeiro ^a   Bartolomé, María Visitación ^d   Fernandes, Aurélia Araújo ^a   Cachofeiro, Victoria ^d   Lahera, Vicente ^d   Salaices, Mercedes ^c   Stefanon, Ivanita ^a   Vassallo, Dalton Valentim ^a,b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Contractility dysfunction; Mercury; Na+ K+ ATPase; SERCA PLB ratio

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COLLAGEN; MERCURY; MYOSIN; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD PRESSURE; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HEMODYNAMICS; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SODIUM CALCIUM EXCHANGE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; HEART; HEART RATE; HISTOCYTOCHEMISTRY; ISOENZYMES; MALE; MERCURIC CHLORIDE; MODELS, ANIMAL; MYOCARDIAL CONTRACTION; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM-CALCIUM EXCHANGER; SODIUM-POTASSIUM-EXCHANGING ATPASE;

RATTUS;

EID: 80051577494     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.06.015     Document Type: Article

References (43)

1. Anner B.M., Moosmayer M., Imesch E. Mercury blocks the Na-K-ATPase by a ligand-dependent and reversible mechanism. Am. J. Physiol. 1992, 262:F830-F836.
2. Assis G.P.S., Silva C.E., Stefanon I., Vassallo D.V. Effects of small concentrations of mercury on the contractile activity of the rat ventricular myocardium. Comp. Biochem. Physiol. C 2003, 134:375-383.
3. Bakir F., Damluji S.F., Amin-Zaqi L., Murtadha M., Khalidi A., al-Rawi N.Y., Tikriti S., Dahahir H.I., Clarkson T.W., Smith J.C., Doherty R.A. Methylmercury poisoning in Iraq. Science 1973, 181:230-241.
4. Bers D.M. Altered cardiac myocyte Ca regulation in heart failure. Physiology 2006, 21:380-387.
5. Bers D.M., Despa S. Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts. J. Pharmacol. Sci. 2006, 100:315-322.
6. Björkman L., Sandborgh-Englund G., Ekstrand J. Mercury in saliva and feces after removal of amalgam fillings. Toxicol. Appl. Pharmacol. 1997, 144:156-162.
7. Björkman L., Lundekvam B.F., Laegreid T., Bertelsen B.I., Morild I., Lilleng P., Lind B., Palm B., Vahter M. Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ. Health 2007, 11:6-30.
8. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:218-254.
9. Cappelli V., Bottinelli R., Poggesi C., Moggio R., Reggiani C. Shortening velocity and myosin and myofibrillar ATPase activity related to myosin isoenzyme composition during postnatal development in rat myocardium. Circ. Res. 1989, 65:446-457.
10. Carmignani M., Boscolo P., Preziosi P. Renal ultraestructural alterations and cardiovascular changes in rats exposed to mercuric chloride. Arch. Toxicol. 1989, 13:353-356.
11. Chan K., Delfert D., Junger K.D. A direct colorimetric assay for Ca2+-ATPase activity. Anal. Biochem. 1986, 157:375-380.
12. Chen C., Qu L., Li B., Xing L., Jia G., Wang T., Gao Y., Zhang P., Li M., Chen W., Chai Z. Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clin. Chem. 2005, 51:759-767.
13. Clarkson T.W. The biological properties and distribution of mercury. Biochem. J. 1972, 130:61-63.
14. Eto K. Minamata disease. Neuropathology 2000, 20:14-19.
15. Furieri L.B., Galán M., Avendaño M.S., García-Redondo A.B., Aguado A., Martínez S., Cachofeiro V., Bartolomé M.V., Alonso M.J., Vassallo D.V., Salaices M. Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is ROS dependent. Br. J. Pharmacol. 2011, 162:1819-1831.
16. Gleason W.L., Braunwald E. Studies on the first derivative of the ventricular pressure pulse in man. J. Clin. Invest. 1962, 41:80-91.
17. Gupta M., Bansal J.K., Khanna C.M. Blood mercury in workers exposed to the preparation of mercury cadmium telluride layers on cadmium telluride base. Ind. Health 1996, 34:421-425.
18. Gutterman D.D., Cowley A.W. Relating cardiac performance with oxygen consumption: historical observations continue to spawn scientific discovery. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:2555-2556.
19. Halbach S. Sulfhydryl-induced restoration of myocardial contractility after alteration by mercury. Arch. Toxicol. 1989, 13:349-352.
20. Halbach S. Combined estimation of mercury species released from amalgam. J. Dent. Res. 1995, 74:1103-1109.
21. Hechtenberg S., Beyersmann D. Inhibition of sarcoplasmic reticulum Ca2+-ATPase activity by cadmium, lead and mercury. Enzyme 1991, 45:109-115.
22. Houston M.C. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern. Ther. Health Med. 2007, 13:128-133.
23. Klotz C., Aumont M.C., Berson G., Leger J.J., Preteseille M., Swynghedauw B. Cardiac myosin, preparation, ATPase in chronic heart hypertrophy. Recent Adv. Stud. Card. Struct. Metab. 1975, 5:263-271.
24. Langworth S., Sallsten G., Barregard L., Cynkier I., Lind M.L., Soderman E. Exposure to mercury vapor and impact on health in the dental profession in Sweden. J. Dent. Res. 1997, 76:1397-1404.
25. Massaroni L., Rossoni L.V., Amaral S.M.C., Stefanon I., Oliveira E.M., Vassallo D.V. Hemodynamic and electrophysiological acute toxic effects of mercury in anaesthetized rats and in Langendorff perfused rat hearts. Pharmacol. Res. 1995, 32:27-36.
26. McKelvey W., Gwyn R.C., Jeffry N., Kass D., Thorpe L.E., Garg R.K., Palmer C.D., Parsons P.J. A biomonitoring study of lead, cadmium, and mercury in the blood of New York City adults. Environ. Health Perspect. 2007, 115:1435-1441.
27. Moreira C.M., Oliveira E.M., Bonan C.D., Sarkis J.J., Vassallo D.V. Effects of mercury on myosin ATPase in the ventricular myocardium of the rat. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2003, 135:269-275.
28. National Academy of Sciences Toxicological Effects of Methylmercury 2000, National Research Council, Washington, DC, USA.
29. Oliveira E.M., Vassallo D.V., Sarkis J.J.F., Mill J.G. Mercury effects on the contractile activity of isolated heart muscle. Toxicol. Appl. Pharmacol. 1994, 128:86-91.
30. Rhee H.M., Choi B.H. Hemodynamic and electrophysiological effects of mercury in intact anesthetized rabbits and in isolated perfused hearts. Exp. Mol. Pathol. 1989, 50:281-290.
31. Rice D.C. The US EPA reference dose for methylmercury: sources of uncertainty. Environ. Res. 2005, 95:406-413.
32. Rooney J.P.K. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 2007, 234:145-156.
33. Rossoni L.V., Amaral S.M.C., Vassallo P.F., França A., Oliveira E.M., Varner K.J., Mill J.G., Vassallo D.V. Effects of mercury on the arterial blood pressure of anesthetized rats. Braz. J. Med. Biol. Res. 1999, 32:989-997.
34. Salonen J.T., Seppanen K., Lakka T.A., Salonen R., Kaplan G.A. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 2000, 148:265-273.
35. Sandborgh-Englund G., Elinder C.G., Johanson G., Lind B., Skare I., Ekstrand J. The absorption, blood levels, and excretion of mercury after a single dose of mercury vapor in humans. Toxicol. Appl. Pharmacol. 1998, 150:146-153.
36. Sjaastad I., Wasserstrom J.A., Sejersted O.M. Heart failure - a challenge to our current concepts of excitation-contraction coupling. J. Physiol. 2003, 546:33-47.
37. Stern A.H. Balancing the risks and benefits of fish consumption. Ann. Intern. Med. 2005, 142:949.
38. Vassallo D.V., Moreira C.M., Oliveira E.M., Bertollo D.M., Veloso T.C. Effects of mercury on the isolated heart muscle are prevented by DTT and Cysteine. Toxicol. Appl. Pharmacol. 1999, 156:113-118.
39. Velema J., Zaagsma J. Purification and characterization of cardiac sarcolemma and sarcoplasmic reticulum from rat ventricle muscle. Arch. Biochem. Biophys. 1981, 212(2):678-688.
40. Virtanen J.K., Voutilainen S., Rissanen T.H., Mursu J., Tuomainen T.P., Korhonen M.J., Valkonen V.P., Seppänen K., Laukkanen J.A., Salonen J.T. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler. Thromb. Vasc. Biol. 2005, 25:228-233.
41. Wiggers G.A., Peçanha F.M., Briones A.M., Pérez-Girón J.V., Miguel M., Vassallo D.V., Cachofeiro V., Alonso M.J., Salaices M. Low mercury concentrations cause oxidative stress and endothelial dysfunction in conductance and resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:1033-1043.
42. Winegrad S., Weisberg A., Lin L.E., McClellan G. Adrenergic regulation of myosin adenosine triphosphatase activity. Circ. Res. 1986, 58:83-95.
43. Zimmer H.G., Millar H.D. Technology and application of ultraminiature catheter pressure transducers. Can. J. Cardiol. 1998, 14:1259-1266.